Bruce Stroever - 04 Jun 2025 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Director
Signature
/s/ Bruce Stroever
Issuer symbol
BBLG
Transactions as of
04 Jun 2025
Net transactions value
$0
Form type
4
Filing time
06 Jun 2025, 17:01:18 UTC
Previous filing
19 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stroever Bruce Director C/O BONE BIOLOGICS CORP,, 2 BURLINGTON WOODS DR.SUITE 100, BURLINGTON, /s/ Bruce Stroever 06 Jun 2025 0001657728

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Non-Employee Stock Option Award $0 +62,894 $0.000000 62,894 04 Jun 2025 Common Stock 62,894 $0.8800 Direct F1
holding BBLG Non-Employee Stock Option 30,713 04 Jun 2025 Common Stock 30,713 $1.73 Direct F2
holding BBLG Non-Employee Stock Option 10,721 04 Jun 2025 Common Stock 10,721 $5.12 Direct F3
holding BBLG Non-Employee Stock Option 154 04 Jun 2025 Common Stock 154 $387.28 Direct F3
holding BBLG Non-Employee Stock Option 37 04 Jun 2025 Common Stock 37 $844.80 Direct F3
holding BBLG Non-Employee Stock Option 13 04 Jun 2025 Common Stock 13 $1260.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments.
F2 This option was granted on 9/17/2024 and vests in four equal quarterly installments.
F3 This option is fully exercisable as of the date of this report.